Company News-Gan & Lee

中文站

Careers | Investors | Patients and HCPS | Contact us

Careers Investors Patients and HCPS Contact us

Search

# Popular search #

Diabetes Oncology Medical Devices

Company News

Company News Exhibitions Activities

All news 2024 2023 2022 2021 2018

Gan & Lee Pharmaceuticals' Dual Insulin Analog GZR101 Completes First Dosing in Phase II Clinical Trial
Gan & Lee 2023-12-11
IDF 2023丨Debut of the Phase III Clinical Evidence in China for Rapilin30
Gan & Lee 2023-12-08
Gan & Lee Pharmaceuticals Announces IND Clearance by the NMPA for the Oral GLP-1 Receptor Agonist (GZR18 Tablet)
Gan & Lee 2023-12-01
Highlights Preview! Gan & Lee Pharmaceuticals' Insulin Aspart 30 Phase III Clinical Study Results Selected for IDF 2023
Gan & Lee 2023-11-29
Gan & Lee Pharmaceuticals Achieves AEO Certification, Initiating a New Era of Efficient Customs Clearance
Gan & Lee 2023-11-13
Gan & Lee Pharmaceuticals Won the Kazakh Government Tender for Insulin Aspart and Insulin Pen
Gan & Lee 2023-11-01

1 2 3 4 >

Our websites

Gangan Technology

You are now leaving the Gan & Lee website.

The site you are about to visit is maintained by a third party who is responsible for its content.
This link is provided on the Gan & Lee website as a service to our visitors. Gan & Lee is not responsible for the privacy policy of any third-party websites. Gan & Lee encourages visitors to read the privacy policy of every website that you may visit.

Continue Back

Search

Subscribe